Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease. (Q53172065)
Jump to navigation
Jump to search
scientific article published on 25 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease. |
scientific article published on 25 April 2016 |
Statements
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease (English)
Beatriz Fernández-Fernández
Rocío Carda
Ana M Pello
Carmen Cristóbal
Nieves Tarín
Álvaro Aceña
Ana Huelmos
Emilio González-Parra
Ignacio Hernández-González
Lorenzo López-Bescós
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference